Showing results (31-40 of 103) with videos related to
Sort By:
Pageof 11
Journal of Cardiovascular Electrophysiology|May 22, 2020
Prognostic implications of nonsustained ventricular tachycardia morphology in high-risk patients with hypertrophic cardiomyopathyCarmen Adduci, Francesca Boldini, Francesca Palano, et al.Giornale Italiano Di Cardiologia (2006)|November 8, 2019
[The subcutaneous implantable cardioverter-defibrillator in clinical practice]Federico Migliore, Giulia Mattesi, Alessandro Zorzi, et al.International Journal of Cardiology|July 5, 2022
Relation of delayed intrinsicoid deflection of the QRS complex to sudden cardiac death in patients with hypertrophic cardiomyopathyPietro Francia, Giacomo Silvetti, Pietro Cosentino, et al.Heart Failure Clinics|March 13, 2025
Arrhythmic Stratification of Cardiac Amyloidosis: State of the ArtRiccardo Scirpa, Federico Follesa, Ludovica De Fazio, et al.Journal of Clinical Medicine|April 30, 2021
Left Ventricular Remodeling in Hypertrophic Cardiomyopathy: An Overview of Current KnowledgeBeatrice Musumeci, Giacomo Tini, Domitilla Russo, et al.Journal of Electrocardiology|June 28, 2015
Electrocardiographic evolution in patients with hypertrophic cardiomyopathy who develop a left ventricular apical aneurysmErmelinda Pennacchini, Maria Beatrice Musumeci, Maria Rosa Conte, et al.American Journal of Hypertension|April 16, 2005
Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonistsFrancesco Cosentino, Carmine Savoia, Paola De Paolis, et al.Journal of Cardiovascular Electrophysiology|May 22, 2015
Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic CardiomyopathyPietro Francia, Carmen Adduci, Francesca Palano, et al.Journal of Cardiovascular Electrophysiology|January 10, 2014
Osteopontin and galectin-3 predict the risk of ventricular tachycardia and fibrillation in heart failure patients with implantable defibrillatorsPietro Francia, Carmen Adduci, Lorenzo Semprini, et al.European Journal of Heart Failure|August 8, 2006
Cardiac resynchronization therapy increases plasma levels of the endogenous inotrope apelinPietro Francia, Adriano Salvati, Cristina Balla, et al.Pageof 11